Kalydeco (ivacaftor)

pCPA File Number: 20938

Negotiation Status:

Concluded without agreement

Indication(s):

Cystic Fibrosis (CFTR gating mutations)

Sponsor/Manufacturer:

Vertex Pharmaceuticals (Canada) Incorporated

CDA-AMC Project Number:

SR0379-000

pCPA Engagement Letter Issued:

2015-01-27

Negotiation Process Concluded:

2017-10-24